康泰医学发布前三季度业绩，归母净利润939.98万元，下降5.08%

Core Viewpoint - 康泰医学 reported a slight increase in revenue for the first three quarters of 2025, but net profit decreased, indicating potential challenges in profitability despite revenue growth [1] Financial Performance - The company's revenue for the first three quarters reached 344 million yuan, representing a year-on-year growth of 3.03% [1] - Net profit attributable to shareholders was 9.3998 million yuan, showing a year-on-year decrease of 5.08% [1] - The net loss attributable to shareholders after excluding non-recurring gains and losses was 3.3972 million yuan [1] - Basic earnings per share were reported at 0.0234 yuan [1]